A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
Objective of this study is to evaluate the safety, tolerability, pharmacokinetics and preliminary pharmacodynamic effects of multiple doses of Gantenerumab in subject with mild to moderate AD.
Epistemonikos ID: 9c433e8cc50a023d6bdba7f2a50a9430e93a82f3
First added on: May 11, 2024